Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on April 1, 2026

Apr. 1, 2026

Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment

Indeterminate GlobeNewswire

Apr. 1, 2026

Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

Indeterminate GlobeNewswire

Apr. 1, 2026

Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year

Indeterminate GlobeNewswire

Apr. 1, 2026

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

Indeterminate GlobeNewswire

Apr. 1, 2026

Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April

Indeterminate GlobeNewswire

Apr. 1, 2026

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

Indeterminate GlobeNewswire

Apr. 1, 2026

Apollomics Inc. Announces $2.0 Million Bridge Financing

Indeterminate GlobeNewswire

Apr. 1, 2026

NewGen Filed 2025 Annual Report on Form 20-F

Indeterminate GlobeNewswire

Apr. 1, 2026

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging

Indeterminate GlobeNewswire

Apr. 1, 2026

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Indeterminate GlobeNewswire

Apr. 1, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

Indeterminate GlobeNewswire

Apr. 1, 2026

Major Shareholder Announcement

Indeterminate GlobeNewswire

Apr. 1, 2026

ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions

Indeterminate GlobeNewswire

Apr. 1, 2026

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Indeterminate GlobeNewswire

Apr. 1, 2026

SpartaMax Claims Evaluated: Powerful Sparta Max Gummies for Maximum Performance Support in Men

Indeterminate GlobeNewswire

Apr. 1, 2026

FibroBiologics Announces Pricing of $3 Million Public Offering

Indeterminate GlobeNewswire